Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
4
Bullish
5
Bearish
17
Neutral
4
Bullish
25
Bearish
12
Neutral
0
Bullish
20
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
5
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Bearish
12
Neutral
0
Bullish
20
Investor Presentation
Q1 FY27
Investor Presentation
Q4 FY26
Gujarat Inject (Kerala) Limited is a publicly listed company historically engaged in pharmaceutical contract manufacturing that has repositioned into solar PV module distribution, renewable energy solutions and operating utility-scale solar assets, and it proposes a corporate rebrand to REGENOVA RENEWTECH LIMITED to reflect this strategic transition and market focus.
The company reported Q1 FY27 standalone revenue of Rs. 12.45 crore, a 414% year-on-year increase driven by recent solar project deliveries, and standalone PAT of Rs. 1.25 crore which represents approximately 69% of FY26 full-year PAT, signaling materially improved profitability and operational leverage from the renewable transition.
Management states the firm owns a 5MW solar plant at Jakasana, Mehsana and is executing 'major solar infrastructure orders,' indicating a pivot from legacy manufacturing toward project execution, asset ownership and solar solution delivery that collectively increase revenue visibility and customer engagement opportunities.
The Board appointed Mr. Murli Shivshankaran Nair as Managing Director effective July 6, 2026 and approved a proposed name change to REGENOVA RENEWTECH LIMITED, demonstrating deliberate leadership strengthening and brand alignment to support planned scale-up in clean energy operations and market positioning.
Pharmaceuticals & Biotechnology
Pharmaceuticals
144 Cr
Low Risk
48.1
34.8
0.2
12.2
14.30
2.06
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
Gujarat Inject (Kerala) Ltd (GUJINJEC) is currently trading at 9.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Gujarat Inject (Kerala) Limited is a publicly listed company historically engaged in pharmaceutical contract manufacturing that has repositioned into solar PV module distribution, renewable energy solutions and operating utility-scale solar assets, and it proposes a corporate rebrand to REGENOVA RENEWTECH LIMITED to reflect this strategic transition and market focus. The company reported Q1 FY27 standalone revenue of Rs. 12.45 crore, a 414% year-on-year increase driven by recent solar project deliveries, and standalone PAT of Rs. 1.25 crore which represents approximately 69% of FY26 full-year PAT, signaling materially improved profitability and operational leverage from the renewable transition. Management states the firm owns a 5MW solar plant at Jakasana, Mehsana and is executing 'major solar infrastructure orders,' indicating a pivot from legacy manufacturing toward project execution, asset ownership and solar solution delivery that collectively increase revenue visibility and customer engagement opportunities. The Board appointed Mr. Murli Shivshankaran Nair as Managing Director effective July 6, 2026 and approved a proposed name change to REGENOVA RENEWTECH LIMITED, demonstrating deliberate leadership strengthening and brand alignment to support planned scale-up in clean energy operations and market positioning.
Over the past 52 weeks, Gujarat Inject (Kerala) Ltd has traded between a low of ₹2.06 and a high of ₹14.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Gujarat Inject (Kerala) Ltd has a market capitalization of approximately 144.29. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Gujarat Inject (Kerala) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 48.10 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 144.29 Cr, Gujarat Inject (Kerala) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Gujarat Inject (Kerala) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Gujarat Inject (Kerala) Ltd is 48.10. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The purchase order is valued at approximately ₹144.9 million (₹14.49 crore) and is stated to be exclusive of GST.
FY26 net profit was ₹1.81 crore, up from ₹1.02 crore in FY25, based on audited standalone results for the year ended March 31, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
133.50 | 153 Cr | 20.46 | 2.08 | 1.12 | 5.54 | 8.84 | 7.16 | ||
9.85 | 144 Cr | 48.10 | 12.18 | 0.00 | 15.34 | 21.17 | 8.18 | ||
176.45 | 143 Cr | 26.61 | 3.81 | 0.00 | 0.00 | 0.00 | 0.00 | ||
29.99 | 142 Cr | 19.73 | 8.01 | 0.00 | 41.95 | 22.81 | 6.97 | ||
129.79 | 142 Cr | 277.98 | 2.13 | 0.00 | 9.95 | 11.89 | 0.99 | ||
82.00 | 134 Cr | 8.95 | 1.39 | 0.00 | 15.51 | 19.06 | 13.51 | ||
212.35 | 132 Cr | 28.22 | 3.08 | 0.00 | 4.47 | 7.31 | 1.55 | ||
| Median: 7 Co. | — | 129.79 | 142 Cr | 26.61 | 3.08 | 0.00 | 9.95 | 11.89 | 6.97 |
